Tg Therapeutics, Inc.

This study looks at how well the multiple sclerosis drug ublituximab works when injected under the skin at different spots on the body, and whether an autoinjector device works as well as a regular syringe. About 350 adults with relapsing MS will take part. The goal is to find th…

This study tests an investigational drug, ublituximab, in children and teens (ages 10-17) with relapsing multiple sclerosis (RMS). The goal is to see if it works better than the current drug fingolimod at reducing relapses, while also checking its safety and how the body processe…

This study tracks 32 people who previously received Azer-Cel, an experimental cell therapy for B-cell autoimmune disorders. The goal is to monitor long-term safety for up to 15 years by recording any significant health events. No new treatment is given; participants are simply ob…